Weed (BUDZ) Accounts Payables (2010 - 2026)
Weed's (BUDZ) quarterly Accounts Payables came in at $182943.0 in Q1 2026, up 7.48% year-on-year from $170208.0 in Q1 2025, and up 1.68% quarter-over-quarter from $179914.0 in Q4 2025.
Weed (BUDZ) Accounts Payables (2010 - 2026) Analysis & Trends
Weed's Accounts Payables history runs 13 years deep, the most recent figure standing at $182943.0 for Q1 2026.
- On a quarterly basis, Accounts Payables rose 7.48% year-over-year to $182943.0 in Q1 2026; TTM through Mar 2026 was $182943.0, a 7.48% increase from a year earlier, with the FY2025 full-year figure at $179914.0, up 7.38% from the prior year.
- Accounts Payables advanced to $182943.0 in Q1 2026 per BUDZ's latest filing, from $179914.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $232856.0 in Q1 2022 and bottomed at $117944.0 in Q2 2022.
- The 5-year median for Accounts Payables is $179914.0 (2025), against an average of $174104.5.
- Across the five-year window, Accounts Payables tumbled 53.64% in 2022 and jumped 35.62% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $189779.0 in 2022, then dropped by 3.27% to $183565.0 in 2023, then decreased by 8.72% to $167552.0 in 2024, then increased by 7.38% to $179914.0 in 2025, then increased by 1.68% to $182943.0 in 2026.
- Per Business Quant, the three latest BUDZ Accounts Payables figures stand at $182943.0 (Q1 2026), $179914.0 (Q4 2025), and $191963.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 182,943.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182,943.00 |
| Dec 31, 2025 | 179,914.00 |
| Sep 30, 2025 | 191,963.00 |
| Jun 30, 2025 | 190,571.00 |
| Mar 31, 2025 | 170,208.00 |
| Dec 31, 2024 | 167,552.00 |
| Sep 30, 2024 | 200,187.00 |
| Jun 30, 2024 | 176,776.00 |
| Mar 31, 2024 | 188,798.00 |
| Dec 31, 2023 | 183,565.00 |
| Sep 30, 2023 | 147,606.00 |
| Jun 30, 2023 | 151,083.00 |
| Mar 31, 2023 | 163,879.00 |
| Dec 31, 2022 | 189,779.00 |
| Sep 30, 2022 | 124,152.00 |
| Jun 30, 2022 | 117,944.00 |
| Mar 31, 2022 | 232,856.00 |
| Dec 31, 2021 | 245,857.00 |
| Sep 30, 2021 | 250,861.00 |
| Jun 30, 2021 | 254,411.00 |